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In this issue, Woods et al
1 report data analyses that sup-
port the validity of the criteria for identifying the
prodrome stage of psychotic disorders. We have previ-
ously placed emphasis on this issue with a special
theme.
2–8 Questions related to the development of Diag-
nostic and Statistical Manual of Mental Disorders (Fifth
Edition) (DSM-V) now emerge. Should clinical practice
move in the direction of early detection of risk status? Do
research findings warrant interventions at the prodrome
stage in general clinical practice? If the answers are yes,
then DSM-V and International Classification of Diseases,
Twelfth Revision, will be challenged to provide clinicians
with a diagnostic category to support this shift in prac-
tice.Thiswillbeanessentialstepforprovidingeducation,
encouraging clinical intervention, and supporting
research on these clinical activities. The DSM-V work-
group responsible for psychotic disorders is considering
creatinganewdiagnosticclassforthispurpose.Although
I chair the DSM-V Psychoses Workgroup, this editorial
represents personal views, not recommendations, of the
Psychosis Workgroup or official decisions of the
DSM-V Task Force. These views are informed, however,
by discussions with workgroup members (http://
www.psych.org/MainMenu/Research/DSMIV/DSMV.
aspx), especially Ming Tsuang, and advisors Tom
McGlashan and Scott Woods.
Anumberofquestionsmustberesolvedbeforemoving
forward.
 Does a critical clinical need exist?
 If so, does Diagnostic and Statistical Manual of Mental
Disorders (Fourth Edition) (DSM-IV) provide diag-
nostic classes that adequately address this need?
 Ifnot, can thereliability and validityachievedbyinves-
tigators be accomplished in clinical practice by primary
care and mental health diagnosticians?
 When prodromal or high-risk cases convert to an
established DSM-IV illness, is it predominantly psy-
chosis? Is it specifically schizophrenia? Should the
new class be placed with the group of psychoses or
placed elsewhere?
 Do the diagnostic criteria reflect behaviors so common
among adolescents and young adults that a valid dis-
tinction between ill and nonill persons is difficult,
resulting in too many false-positive diagnoses?
 Will placing individuals in this diagnostic category
do more harm than good because of stigma or the un-
warranted administration of treatments with a poor
benefit/risk ratio?
Studies in a number of countries document the validity
of prepsychosis risk detection by observing nontrivial
rates of conversion to psychosis in a short time period
(Woods et al
1). Data from controlled studies suggest
that clinical intervention may be effective in delaying
or preventing exacerbation into psychosis, but evidence
to date is very weak.
9,10 Screening for psychosis risk is
certainlycontroversial.
11,12Nonetheless,thereisaclinical
need for methods of identification and intervention pre-
ceding fully manifest psychosis. Predictive power for pro-
gression along this path is enhanced by family history of
psychotic illness, but the gain in predictive accuracy is
offset by a sharply reduced sensitivity to detect cases,
thus creating many false-negative classifications. En-
hancing risk determination using endophenotype and
biomarker assessment is a future goal, but current con-
sideration of risk criteria for clinical application depends
largely on manifest psychopathology. Success with these
criteriatodatesuggestsacompellingneedforadiagnostic
class, a view supported by the help-seeking status of cases
and families in these studies.
An adequate approach is not provided in DSM-IV.
The state-like and duration-related criteria exclude
these cases from trait-like personality diagnoses includ-
ing schizotypal personality disorder. Cases are also
excluded if they manifest fully formed psychotic symp-
t o m s .T h i sr e p r e s e n t s‘ ‘ c o n verting,’’ and psychosis
diagnoses are then applicable. Over time, if the prodro-
mal symptom criteria are stable, the case may meet
schizotypal personality disorder criteria, but this is
not useful for early intervention. Eventually, cases
may meet other criteria such as those for mood disor-
der,ortheymaysimplyrecoverandnothaveadefinitive
diagnosis. Hence, there is space for a risk syndrome
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841class that allows for various outcomes but is redundant
with no other diagnostic class.
The prodrome or high-risk concept (of which there are
several versions) can be assessed in individuals with
sufficient reliability and validity to justify potential appli-
cation as a diagnostic class. However, it remains to be
determined if utility in research will generalize to clinical
practice.Worktodatehasbeenbasedonformaldiagnos-
tic assessment interviews and supplemental information
often not available in general practice. Reliable and valid
application of criteria may be especially challenging in
primary care and in areas with inadequate numbers
of trained psychiatrists. For DSM-V, this means that
reliability of proposed criteria must be evaluated in field
trials.
The question of where to place a new class is compli-
cated. The work to date has been oriented to risk for psy-
chotic disorders, and the criteria are mainly minor
expressionsofpsychotic-likepsychopathology.Casecon-
versionis generallybasedonincreasingsymptomseverity
resulting in recognition of psychosis. Diagnosis on con-
version usually falls not only within the Schizophrenia
and Related Disorders section but also mood disorders
with psychotic features. The field will, no doubt, develop
risk criteria for other diagnostic groups, but at present
the work relates to the psychoses. Thus, the natural
home for a new diagnostic class is with the psychotic dis-
orders. However, the resulting potential for stigma and
unwarranted treatment merits caution. Psychotic-like
phenomena are fairly common in the general population,
as Woods et al
1 (this issue) point out. Establishing a men-
tal illness diagnosis and initiating treatment are stigma-
tizing and can cause harm to individuals. Initiation of
treatment can have adverse effects, especially associated
with antipsychotic drugs. Clinicians could be caught
between 2 compelling, but mutually exclusive, goals:
identify illness and institute treatment at the earliest
and most effective time vs the traditional mandate in
medicine—‘‘first of all, do no harm.’’
Itseemspossibletoreconcilethesegoals.Thefirsttaskis
toassurethatthediagnosisisnotappliedtononillpersons.
Inthisregard,itisworthkeepinginmindthatmostcriteria
for any DSM-IV diagnosis are based on behaviors on
a continuum of human experience. Consider anxiety, or
the experience of sadness, aggressiveness, or memory
problems. The validity of psychiatric diagnosis rests
heavily on the general criteria of distress, dysfunction,
and/ordisability.Itistheseattributesthatpromptindivid-
uals or families to seek help. If DSM-V is to succeed
with this class, it is crucial that the diagnosis be applied
inthecontextofillnessasdefinedbydistress,dysfunction,
and/or disability. Suspiciousness without impaired func-
tion or dysphoria will not qualify for the diagnosis.
The second aspect, do no harm, is also a valid concern.
If this new diagnosis leads to therapeutic procedures in
which cost and/or adverse effects outweigh benefit,
harm results. Therefore, it will be important to provide
effective treatment guidelines supported with scientific
evidence.Apresumption,eg,thatallormostcasesofpro-
drome should be placed on antipsychotic medication
would not be evidence based and would cause harm.
At present, clinical care approaches will be based on
stress reduction while monitoring for symptomatic exac-
erbation. Studies now underway may provide more spe-
cific information on the effectiveness of psychosocial
treatments, judicious use of medications, and integration
of therapeutic technique.
The field will be challenged to manage this new class
prudently. But, without the class, a framework for early
detection and intervention is lost, and the opportunity to
develop evidence-based treatment will be minimized. In
my view, DSM-V must represent that which is scientifi-
cally valid even if concern for potential misuse is serious.
The prodrome, as a class within the psychoses frame-
work, may parallel attention deficit/hyperactivity disor-
der in potential for public misunderstanding and in the
possibility of therapeutic approaches in some individuals
where risks are greater than benefits. Establishing a clear
boundary between ill and nonill and restricting therapy
to the former cases and implementation of prudent,
evidence-based care will be essential in meeting our
clinical care obligations. It will also be the most effective
way to combat the expected criticism that another
category is being created to justify the marketing of drugs
to nonill populations.
The issue of stigma must be addressed in DSM-V.
Words have connotations, and naming things creates an
initial orientation. Prodrome is not a good choice for
the new class. It has a different meaning as defined in
DSM-IV,andthe‘‘prodromeofwhat’’questionisnotad-
equatelyanswered.Of psychosisgenerally,yes,butnotto
a specific class. S. Heckers, MD (personal communica-
tion, 2009) has made the interesting suggestion that
DSM-V create a new grouping that would comprise
risk syndromes. ‘‘Risk syndrome for psychosis’’ is less
problematic than ‘‘prodrome’’ that has a different defini-
tion in DSM-IV and may address aspects of stigma if
shortenedto‘‘risk syndrome.’’Sucha groupingwould al-
low space for other risk syndromes to be developed
including risk dimensions that are not disease per se.
Elevated blood pressure and abnormal glucose indices
are risk syndromes with multiple possible disease
outcomes. Assessment and treatment of these conditions
areessentialbecauseoftheirinherentrisk.Thesamelogic
holdstruefortherisksyndromeassociatedwithpsychosis.
However, caution is necessary,
11–13 and quasi-psychotic
features are not uncommon in the nonill population.
14
Concerning schizophrenia, we anticipate an increasing
ability to detect early morbid manifestations (eg, im-
paired cognition or avolition) with endophenotypes or
biomarkers that relate assessment to potential disease
class. As therapies are developed, it will be imperative
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842to determine if early intervention (perhaps years in ad-
vance of psychosis) is effective and favorably alters the
future course of illness. The rubric of risk syndromes
would facilitate evolution in the understanding of disease
trajectories and refinement of early treatment. Further-
more, DSM-V may have a dynamic format in order to
facilitate timely communication based on advances in in-
formation technology. An evidence-based approach to
psychiatric diagnosis requires the integration of new in-
formation as it is established rather than waiting for the
next DSM publication.
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